
Results
18
Undervalued Small Caps
18 companies
Consun Pharmaceutical Group
Market Cap: HK$11.3b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$13.48
7D
8.0%
1Y
21.9%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩255,000.00
7D
1.0%
1Y
-29.6%
Diaceutics
Market Cap: UK£123.6m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.46
7D
0.7%
1Y
25.3%
Pharma Mar
Market Cap: €1.4b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€80.15
7D
9.8%
1Y
-4.4%
Abeona Therapeutics
Market Cap: US$364.8m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$6.40
7D
14.1%
1Y
8.7%
Zevra Therapeutics
Market Cap: US$826.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$13.98
7D
3.4%
1Y
43.5%
Clinuvel Pharmaceuticals
Market Cap: AU$516.9m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.25
7D
2.6%
1Y
0.9%
Kuros Biosciences
Market Cap: CHF 754.5m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 19.12
7D
4.6%
1Y
-32.0%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €213.6m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€9.08
7D
2.5%
1Y
15.8%
Collegium Pharmaceutical
Market Cap: US$1.2b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$37.03
7D
1.2%
1Y
22.0%
ANI Pharmaceuticals
Market Cap: US$1.8b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$86.03
7D
1.8%
1Y
31.8%
Saudi Pharmaceutical Industries and Medical Appliances
Market Cap: ر.س3.5b
Develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, Algeria, and Morocco.
2070
ر.س28.78
7D
0.7%
1Y
9.4%
AcrobiosystemsLtd
Market Cap: CN¥8.2b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥48.89
7D
11.8%
1Y
-4.0%
Faes Farma
Market Cap: €1.4b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.63
7D
0.2%
1Y
2.2%
Bonesupport Holding
Market Cap: SEK 14.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 224.60
7D
9.3%
1Y
-22.3%
Devyser Diagnostics
Market Cap: SEK 1.0b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 60.70
7D
-28.6%
1Y
-53.3%
China Animal Husbandry Industry
Market Cap: CN¥6.4b
Engages in research, development, production, sales, and technical services of animal health and nutrition products in China and internationally.
600195
CN¥6.25
7D
5.2%
1Y
-14.6%
Strides Pharma Science
Market Cap: ₹103.9b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹1,126.80
7D
4.1%
1Y
27.3%